Epidemiology, natural history and treatment of hepatitis C virus infection in injecting drug users

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

In Australia, the majority of hepatitis C is acquired by injecting drug users (IDUs). Given the asymptomatic nature of infection and difficulties in identifying and following those at risk of acquiring infection, our knowledge of hepatitis C has been hampered. The overall goal of this proposed research is to assess markers to better diagnose and predict clearance of hepatitis C, assess hepatitis C transmission and assess health services to enhance HCV assessment and treatment among IDUs.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Career Development Fellowships

Funding Amount: $408,388.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

access to health care | epidemiology | hepatitis C virus | injecting drug use | natural history | treatment